Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David M Rind

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia BJyotirmoy Sarker, Jeffrey A Tice, David M Rind, et al.
Archives of Internal Medicine|March 18, 2003
Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care settingC Christopher Smith, Lana I Bernstein, Roger B Davis, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes MellitusKatherine T Fazioli, David M Rind, Gregory F Guzauskas, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's diseasePatricia G Synnott, Melanie D Whittington, Grace A Lin, et al.
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitorsFoluso Agboola, David M Rind, Surrey M Walton, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular DystrophyFoluso Agboola, Grace A Lin, Noemi Fluetsch, et al.
Journal of Managed Care & Specialty Pharmacy|January 28, 2021
The effectiveness and value of novel treatments for cystic fibrosisJeffrey A Tice, Karen M Kuntz, Kael Wherry, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Mavacamten for hypertrophic cardiomyopathy: effectiveness and valueMolly Beinfeld, Jason H Wasfy, Surrey Walton, et al.
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2020
The effectiveness and value of novel acute treatments for migraineFoluso Agboola, Steven J Atlas, Daniel R Touchette, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Journal of Managed Care & Specialty Pharmacy|August 1, 2024
The impact of capping health system cost savings on the projected cost-effectiveness of etranacogene dezaparvovec compared with factor IX prophylaxis for the treatment of hemophilia BJyotirmoy Sarker, Jeffrey A Tice, David M Rind, et al.
Archives of Internal Medicine|March 18, 2003
Screening for statin-related toxicity: the yield of transaminase and creatine kinase measurements in a primary care settingC Christopher Smith, Lana I Bernstein, Roger B Davis, et al.
Journal of Managed Care & Specialty Pharmacy|August 29, 2020
The Effectiveness and Value of Oral Semaglutide for Type 2 Diabetes MellitusKatherine T Fazioli, David M Rind, Gregory F Guzauskas, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2021
The effectiveness and value of aducanumab for Alzheimer's diseasePatricia G Synnott, Melanie D Whittington, Grace A Lin, et al.
Journal of Managed Care & Specialty Pharmacy|April 28, 2021
The effectiveness and value of emicizumab and valoctocogene roxaparvovec for the management of hemophilia A without inhibitorsFoluso Agboola, David M Rind, Surrey M Walton, et al.
Journal of Managed Care & Specialty Pharmacy|April 1, 2020
The Effectiveness and Value of Deflazacort and Exon-Skipping Therapies for the Management of Duchenne Muscular DystrophyFoluso Agboola, Grace A Lin, Noemi Fluetsch, et al.
Journal of Managed Care & Specialty Pharmacy|January 28, 2021
The effectiveness and value of novel treatments for cystic fibrosisJeffrey A Tice, Karen M Kuntz, Kael Wherry, et al.
Journal of Managed Care & Specialty Pharmacy|February 24, 2022
Mavacamten for hypertrophic cardiomyopathy: effectiveness and valueMolly Beinfeld, Jason H Wasfy, Surrey Walton, et al.
Journal of Managed Care & Specialty Pharmacy|October 27, 2023
Gene therapies for sickle cell disease: Effectiveness and valueDmitriy Nikitin, Francesca L Beaudoin, Praveen Thokala, et al.
Journal of Managed Care & Specialty Pharmacy|October 29, 2020
The effectiveness and value of novel acute treatments for migraineFoluso Agboola, Steven J Atlas, Daniel R Touchette, et al.
Pageof 5